Error: Could not add to watchlist. X

Vericel Corp

+ Watchlist
ATQN:GR
Ticker Change
ATQN:GR has changed to a new ticker symbol
EUR
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Medical Equipment & Devices
Sub-Industry
Life Science Equipment

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Vericel Corp develops autologous stem/progenitor cell products for the repair/regeneration of tissues based on Tissue Repair Cell (TRC) adult stem cell technology. The Company's products contain bone marrow stem and progenitor cells that are produced from cells originating from the patient.
ADDRESS
64 Sidney Street
Cambridge, MA 02139
United States
PHONE
1-617-252-7999
  • Dominick C Colangelo "Nick"
    Pres/CEO/Chief Acctg Officer
  • Daniel Orlando "Dan"
    Chief Operating Officer
  • Ross Tubo
    Chief Scientific Officer
  • David Recker
    Chief Medical Officer
  • Gerard J Michel
    VP:Corporate Dev/CFO/Secretary
Show More